ROXANNE ALANIZ, CEO, Alaniz Health
“Now is the time for bold, equity-centered innovation. Yes, the political landscape is changing—but with the right strategy, clinical research and healthcare equity efforts can come back stronger, more inclusive, and more impactful than ever.”
Health Equity Leader | Speaker | Advocate for Inclusive Clinical Research
alaniz.health | roxanne@alanizmarketing.com | LinkedIn
SPEAKING TOPICS
- The Healthcare Equity Gap: How To Engage Underserved and Underrepresented Communities
- A Guide to NIH Healthcare Research and Funding Under the New Administration
- Rebranding DEI in Clinical Research – How To Continue to Engage Diverse Audiences In Research without Getting Your Grant Cancelled
- Thriving in the New Political Environment: What Researchers Need to Know To Thrive Under New Administration Policies
- Bridging the Gap: Connecting Underserved Communities to Groundbreaking Research
MEET ROXANNE
Roxanne Alaniz is the visionary founder and CEO of Alaniz Health, a leading agency dedicated to clinical research equity. Roxanne is a national thought leader and strategic advisor to some of the country’s top-funded researchers, university research teams, and NIH-connected institutions.
Under her leadership, Alaniz Health has connected thousands of individuals from underserved and underrepresented communities to vital clinical trials—helping researchers meet recruitment goals, improve data diversity, and build long-term community trust.
She is an in-demand speaker known for breaking down complex federal policy shifts and translating them into actionable guidance for academic institutions, CROs, and pharma sponsors. Roxanne’s unique perspective blends insider access to NIH and policy circles with a deep understanding of on-the-ground research operations and communications strategy.
IMPACT
➤ Working Toward the Cure for Alzheimer’s Disease, For Everyone – Alaniz Health has teamed up with clinical researchers to attract thousands of individuals who are underrepresented in brain health research to participate in their studies, including:
- UCSF Brain Health Registry
- Alzheimer’s Disease Neuroimaging Initiative (ADNI)
- The Community Engaged Digital Alzheimer’s Research (CEDAR) Study
➤ Raising Awareness of Black Men’s Brain Health – Alaniz Health partnered with researchers to raise awareness and generate dialogue surrounding Alzheimer’s, dementia, CTE and mental health among Black men.
➤ Saving Lives From Covid – Alaniz Health partnered with Marin Community Clinics to help improve access to healthcare and provide education surrounding COVID health for our communities who need it most.
➤ Stopping Fentanyl Overdoses – Alaniz Health partnered with Hikma and Velocity Bio Group to build public awareness of the dangers of fentanyl and educating on overdose reversal.
➤ Keeping Tribal Communities Connected – Alaniz partnered with Yurok Telecommunications Corporation and the Yurok Indigenous American Tribe provide high speed internet access to their people, connecting them to tele-health, emergency services, education, and economic opportunity.
WHY BOOK ROXANNE?
With the current political tides shifting sharply and threatening the future of federally funded research, Roxanne offers a rare mix of access, insight, and optimism. She delivers insider knowledge about:
- NIH policy changes and executive orders
- How institutions are adjusting grant language to stay competitive
- Ways to future-proof diversity initiatives and maintain compliance
- Strategies to continue advancing inclusive research even amid funding uncertainty
SPEAKING HIGHLIGHTS
- Alaniz Health Webinar Series: Navigating the Changing Landscape of Healthcare Research
- BioPharma E Marketing Summit (2024): “Serving Underserved Patient Populations in Clinical Research: Connecting You with Diverse Communities”
- UC Davis Clinical Research Educational Track (2025)
-
- Engaging Underrepresented Populations in Clinical Research: Overcoming Barriers and Building Trust
- Diversity Alliance for Science National Conference (2025): “How to Navigate The Changing Political Landscape in Healthcare Research”
BioPharma eMarketing Summit 2024: Watch Keynote
ALANIZ HEALTH WEBINAR SERIES
Reframing Clinical Trial Communications: Patient Engagement in a Post-DEI World – April 2025
Navigating the Changing Landscape of Healthcare Research: Strategies to Adapt, Pivot, and Thrive in 2025 and Beyond – March 2025
RECOGNITION & HONORS
2024 Netty Award – Multicultural Healthcare Design
Top 100 Fastest Growing Businesses, Top 100 Women-Owned, Top 100 BIPOC-Owned – San Francisco Business Times, 2024
Ervin “Magic” Johnson Healthcare & Business Award Nominee (2024) – Diversity Alliance for Science
COAUTHORED CLINICAL JOURNAL PUBLICATIONS
“The CEDAR Study: A Digital Intervention to Increase Research Participation of Black American Participants in the Brain Health Registry,” The Journal of Prevention of Alzheimer’s Disease
“Digital Culturally Tailored Marketing for Enrolling Latino Participants in a Web-based Registry: Baseline metrics from the Brain Health Registry,” Alzheimer’s & Dementia, The Journal of the Alzheimer’s Association
BOOK ROXANNE ALANIZ
To schedule Roxanne for your upcoming event, keynote, webinar, or summit, contact:
Esteffani Nevarez | esteffani@alanizmarketing.com | alaniz.health